elvanse 60 mg hartkapseln
takeda pharmaceuticals international ag t/a takeda pharmaceuticals international ag ireland branch (1009404) - lisdexamfetamindimesilat - hartkapsel - teil 1 - hartkapsel; lisdexamfetamindimesilat (37246) 60 milligramm
elvanse 40 mg hartkapseln
takeda pharmaceuticals international ag t/a takeda pharmaceuticals international ag ireland branch (1009404) - lisdexamfetamindimesilat - hartkapsel - teil 1 - hartkapsel; lisdexamfetamindimesilat (37246) 40 milligramm
elvanse
takeda pharmaceuticals international ag t/a takeda pharmaceuticals international ag ireland branch (1009404) - lisdexamfetamindimesilat - hartkapsel - teil 1 - hartkapsel; lisdexamfetamindimesilat (37246) 70 milligramm
elvanse
takeda pharmaceuticals international ag t/a takeda pharmaceuticals international ag ireland branch (1009404) - lisdexamfetamindimesilat - hartkapsel - teil 1 - hartkapsel; lisdexamfetamindimesilat (37246) 30 milligramm
elvanse 20 mg hartkapseln
takeda pharmaceuticals international ag t/a takeda pharmaceuticals international ag ireland branch (1009404) - lisdexamfetamindimesilat - hartkapsel - teil 1 - hartkapsel; lisdexamfetamindimesilat (37246) 20 milligramm
takhzyro
takeda pharmaceuticals international ag ireland branch - lanadelumab - angioödeme, erblich - other hematological agents - takhzyro is indicated for routine prevention of recurrent attacks of hereditary angioedema (hae) in patients aged 2 years and older.
elvanse
takeda pharmaceuticals international ag t/a takeda pharmaceuticals international ag ireland branch (1009404) - lisdexamfetamindimesilat - hartkapsel - teil 1 - hartkapsel; lisdexamfetamindimesilat (37246) 50 milligramm
elvanse erwachsene 20 mg hartkapseln
takeda pharmaceuticals international ag ireland branch - lisdexamfetamin dimesylat -
elvanse erwachsene 40 mg hartkapseln
takeda pharmaceuticals international ag ireland branch - lisdexamfetamin dimesylat -
elvanse erwachsene 60 mg hartkapseln
takeda pharmaceuticals international ag ireland branch - lisdexamfetamin dimesylat -